Indeed, we were able to detect AR-V567es in one out of more than 200 clinical specimen only, which is in stark contrast to studies demonstrating appearance of AR-V567es in up to 70% of prostate cancer patients [20, 21]. This evidence concerns the gene AR and prostate carcinoma.